Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer by Quisette P. Janssen, Eileen M. O'Reilly, Eileen M. O'Reilly, Casper H. J. van Eijck, Bas Groot Koerkamp

Get full text

Duration of therapy for locally advanced pancreatic cancer: Does it matter? by Richard Tuli, John David, Stephanie Lobaugh, Zhigang Zhang, Eileen M. O'Reilly

Get full text

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study by Ritu R. Singh, Alison P. Klein, Neil R. Sharma, Eileen M. O'Reilly

Get full text

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior by Ibrahim H. Sahin, Harold Elias, Joanne F. Chou, Marinela Capanu, Eileen M. O’Reilly

Get full text

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma by Kenneth H. Yu, Paul Cockrum, Andy Surinach, Neil Lamarre, Shu Wang, Eileen M. O'Reilly

Get full text

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes by Eileen M. O'Reilly, Paul Cockrum, Andy Surinach, Zheng Wu, Allison Dillon, Kenneth H. Yu

Get full text

Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge by Fergus Keane, Raazi Bajwa, Pier Selenica, Wungki Park, Michael H. Roehrl, Jorge S. Reis-Filho, Diana Mandelker, Eileen M. O’Reilly

Get full text

Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients by Mashaal Dhir, Gautam K. Malhotra, Davendra P.S. Sohal, Nicholas A. Hein, Lynette M. Smith, Eileen M. O’Reilly, Nathan Bahary, Chandrakanth Are

Get full text

Acquired resistance to immunotherapy in MMR-D pancreatic cancer by Zishuo Ian Hu, Matthew D. Hellmann, Jedd D. Wolchok, Monika Vyas, Jinru Shia, Zsofia K. Stadler, Luis A. Diaz, Eileen M. O’Reilly

Get full text

Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer by Agnieszka K. Witkiewicz, Uthra Balaji, Cody Eslinger, Elizabeth McMillan, William Conway, Bruce Posner, Gordon B. Mills, Eileen M. O’Reilly, Erik S. Knudsen

Get full text

Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes by Lilly Gu, Paras P. Mehta, Devika Rao, Veronica Rotemberg, Marinela Capanu, Joanne Chou, Sabrina Lin, Carlie S. Sigel, Klaus J. Busam, Lindsay Boyce, Allison Gordon, Eileen M. O'Reilly

Get full text

Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study by Saroj Vadhan‐Raj, Mairéad G. McNamara, Marino Venerito, Hanno Riess, Eileen M. O'Reilly, Michael J. Overman, Xiao Zhou, Ujjwala Vijapurkar, Simrati Kaul, Peter Wildgoose, Alok A. Khorana

Get full text

Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032) by Padmanee Sharma, Asim Amin, Dung T Le, Michael A Morse, Marina Tschaika, Matthew H Taylor, Margaret Callahan, Katriina J Peltola, Frederic J Kaye, Eileen M O'Reilly, Stephanie Meadows Shropshire, Shaun O'Brien

Get full text

Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system by Kathryn R. Tringale, Neelam Tyagi, Marsha Reyngold, Paul B. Romesser, Abraham Wu, Eileen M. O'Reilly, Anna M. Varghese, Paola Godoy Scripes, Danny N. Khalil, Wungki Park, Kenneth Yu, Christopher H. Crane

Get full text

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib by Imane El Dika, Marinela Capanu, Joanne F. Chou, James J. Harding, Michele Ly, Anna D. Hrabovsky, Richard K.G. Do, Jinru Shia, Brittanie Millang, Jennifer Ma, Eileen M. O’Reilly, Ghassan K. Abou‐Alfa

Get full text

115 Comprehensive spatial, transcriptomic, and genomic analysis of immunogenic biliary tract cancer by James Harding, Allison Richards, Dae Won Kim, Wungki Park, Kevin Soares, Danny Khalil, Olca Basturk, Mark Donoghue, William Jarnagin, Darren Cowzer, Ghassan Abou-Alfa, Fergus Keane, Hulya Sahin Ozkan, Vasilisa Rudneva, Bruno A Costa, Zeyneb Tarcan, Eileen M O’Reilly

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers. by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen

Get full text

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. by Jordan M Winter, Laura H Tang, David S Klimstra, Murray F Brennan, Jonathan R Brody, Flavio G Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I D'Angelica, Ronald P DeMatteo, Yuman Fong, William R Jarnagin, Eileen M O'Reilly, Peter J Allen

Get full text

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited meta... by Kathryn E. Hitchcock, Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White, Christina Wu, Christopher C. Goulet, Manju George, Kyung-Wook Jee, Chadwick L. Wright, Rona Yaeger, Ardaman Shergill, Theodore S. Hong, Thomas J. George, Eileen M. O’Reilly, Jeffrey A. Meyerhardt, Paul B. Romesser

Get full text

765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of t... by Robert H Vonderheide, Andrew H Ko, Danny Khalil, Oliver Rosen, Robert A Wolff, James Francis, Samantha Bucktrout, Christopher R Cabanski, Silvia Boffo, Zev A Wainberg, Samik Upadhaya, Eileen M O’Reilly, Mark H O’Hara, George Fisher, Jamie Arnott, Ana Rosa Saez-Ibanez, Jay Campbell, Ute Dugan, Jill O’Donnell-Tormey